Status:
COMPLETED
A Survey on Low Blod Sugar Among Insulin-treated Patients With Diabetes
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 1
Eligibility:
All Genders
Brief Summary
This study is conducted globally. The aim of this study is to describe the proportion of patients with hypoglycaemic episodes and estimate the incidence of various types of hypoglycaemia in the retros...
Eligibility Criteria
Inclusion
- Informed consent obtained before any trial-related activities
- Patient with T1DM or T2DM treated with insulin for more than 12 months
- Male or female patient at least 18 years of age at the time of inclusion in the study
Exclusion
- Previous participation in this study
- Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
- Illiterate patients and patients otherwise unable to sign the Informed Consent or complete a written survey
- Non-ambulatory patients
- Simultaneous participation in any other clinical study with an investigational product
Key Trial Info
Start Date :
October 30 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 14 2015
Estimated Enrollment :
7315 Patients enrolled
Trial Details
Trial ID
NCT02306681
Start Date
October 30 2014
End Date
May 14 2015
Last Update
March 8 2019
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Dhaka, Bangladesh, 1000
2
Novo Nordisk Investigational Site
Bogotá, Colombia, 1
3
Novo Nordisk Investigational Site
Cairo, Egypt
4
Novo Nordisk Investigational Site
Manila, Philippines, 1605